Clinical trials
Completed Clostridium Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 6 |
| 2011 | 6 |
| 2012 | 10 |
| 2013 | 9 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 12 |
| 2017 | 12 |
| 2018 | 9 |
| 2019 | 13 |
| 2020 | 6 |
| 2021 | 7 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 4 |
| Mayo Clinic | 4 |
| Rebiotix Inc. | 4 |
| AstraZeneca | 3 |
| Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Sanofi Pasteur, a Sanofi Company | 3 |
| Seres Therapeutics, Inc. | 3 |
| Summit Therapeutics | 3 |
| University of Wisconsin, Madison | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clostridium Infections | 128 |
| Diarrhea | 22 |
| Cross Infection | 6 |
| Enterocolitis, Pseudomembranous | 6 |
| Bacterial Infections | 3 |
| Communicable Diseases | 3 |
| Diabetes Insipidus, Neurogenic | 3 |
| Gastrointestinal Diseases | 3 |
| Inflammatory Bowel Diseases | 3 |
| Pneumonia | 3 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.